InterCure Ltd. (INCR.TA)
ILA 517.4
(-1.45%)
ILA 517.4
(-1.45%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -41.56 Million ILS | -178.72% |
| 2022 | 52.8 Million ILS | 87.32% |
| 2021 | 28.18 Million ILS | 2046.69% |
| 2020 | -1.44 Million ILS | 98.19% |
| 2019 | -80.13 Million ILS | -654.43% |
| 2018 | -10.62 Million ILS | -166.68% |
| 2017 | -3.98 Million ILS | -430.82% |
| 2016 | 1.2 Million ILS | 147.97% |
| 2015 | -2.51 Million ILS | -193.97% |
| 2014 | 2.67 Million ILS | 237.96% |
| 2013 | -1.93 Million ILS | 10.95% |
| 2012 | -2.17 Million ILS | -20.52% |
| 2011 | -1.8 Million ILS | 63.94% |
| 2010 | -5 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 5.25 Million ILS | 119.71% |
| 2024 Q2 | 5.25 Million ILS | 0.0% |
| 2023 Q4 | -26.66 Million ILS | -301.55% |
| 2023 FY | -41.56 Million ILS | -178.72% |
| 2023 Q1 | 5.94 Million ILS | 478.31% |
| 2023 Q2 | 5.82 Million ILS | -2.14% |
| 2023 Q3 | -6.64 Million ILS | -214.11% |
| 2022 Q3 | 16.18 Million ILS | -9.72% |
| 2022 Q4 | -1.57 Million ILS | -109.71% |
| 2022 FY | 52.8 Million ILS | 87.32% |
| 2022 Q1 | 19.98 Million ILS | 120.79% |
| 2022 Q2 | 17.92 Million ILS | -10.32% |
| 2021 Q2 | 8.87 Million ILS | 73.55% |
| 2021 Q4 | 9.05 Million ILS | 99.36% |
| 2021 FY | 28.18 Million ILS | 2046.69% |
| 2021 Q1 | 5.11 Million ILS | -31.37% |
| 2021 Q3 | 4.54 Million ILS | -48.86% |
| 2020 FY | -1.44 Million ILS | 98.19% |
| 2020 Q2 | -847 Thousand ILS | 98.21% |
| 2020 Q3 | 2.37 Million ILS | 380.64% |
| 2020 Q1 | -47.38 Million ILS | -251.59% |
| 2020 Q4 | 7.45 Million ILS | 213.59% |
| 2019 Q3 | -14.43 Million ILS | -40.19% |
| 2019 Q1 | 37.68 Million ILS | 862.64% |
| 2019 Q2 | -10.29 Million ILS | -127.32% |
| 2019 FY | -80.13 Million ILS | -654.43% |
| 2019 Q4 | -13.47 Million ILS | 6.6% |
| 2018 Q4 | -4.94 Million ILS | 0.0% |
| 2018 Q2 | -126 Thousand ILS | 0.0% |
| 2018 FY | -10.62 Million ILS | -166.68% |
| 2018 Q1 | -126 Thousand ILS | 63.27% |
| 2018 Q3 | -4.94 Million ILS | -3821.43% |
| 2017 Q4 | -343.06 Thousand ILS | -0.0% |
| 2017 FY | -3.98 Million ILS | -430.82% |
| 2017 Q3 | -343.06 Thousand ILS | -50.15% |
| 2017 Q2 | -228.48 Thousand ILS | 3.69% |
| 2017 Q1 | -237.23 Thousand ILS | -238.32% |
| 2016 FY | 1.2 Million ILS | 147.97% |
| 2016 Q1 | 1.29 Million ILS | 259.87% |
| 2016 Q2 | -593.81 Thousand ILS | -145.93% |
| 2016 Q3 | 326.63 Thousand ILS | 155.01% |
| 2016 Q4 | 171.5 Thousand ILS | -47.49% |
| 2015 Q2 | -283.47 Thousand ILS | 14.71% |
| 2015 Q4 | -808.74 Thousand ILS | 24.88% |
| 2015 Q3 | -1.07 Million ILS | -279.77% |
| 2015 Q1 | -332.37 Thousand ILS | -106.94% |
| 2015 FY | -2.51 Million ILS | -193.97% |
| 2014 Q2 | -1.06 Million ILS | -105.33% |
| 2014 Q1 | -518.26 Thousand ILS | -141.11% |
| 2014 FY | 2.67 Million ILS | 237.96% |
| 2014 Q4 | 4.78 Million ILS | 1219.64% |
| 2014 Q3 | -427.52 Thousand ILS | 59.83% |
| 2013 Q1 | -1.2 Million ILS | 5.52% |
| 2013 Q2 | -1.51 Million ILS | -25.95% |
| 2013 FY | -1.93 Million ILS | 10.95% |
| 2013 Q3 | -542.33 Thousand ILS | 64.18% |
| 2013 Q4 | 1.26 Million ILS | 332.45% |
| 2012 Q1 | -300.9 Thousand ILS | 0.0% |
| 2012 Q3 | -7878.04 ILS | 98.62% |
| 2012 FY | -2.17 Million ILS | -20.52% |
| 2012 Q4 | -1.27 Million ILS | -16049.72% |
| 2012 Q2 | -571.31 Thousand ILS | -89.87% |
| 2011 FY | -1.8 Million ILS | 63.94% |
| 2010 FY | -5 Million ILS | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cannabotech LTD | -16.62 Million ILA | -150.027% |